The Food and Drug Administration ("FDA") finalized its guidance on how manufacturers of certain drug products should present quantitative efficacy and risk information in promotion directed to ...
The discussion of “evaluating whether a judicial exception is integrated into a practical application” includes a specific discussion of personalized medicine claims. The October 2019 PEG Update also ...
In new guidance on patent subject matter eligibility, the USPTO has responded to six themes brought up in feedback on last year’s interim guidance. IP practitioners say new examples provided with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results